AUPH
Price
$8.19
Change
+$0.09 (+1.11%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
1.11B
6 days until earnings call
RHP
Price
$86.32
Change
-$0.35 (-0.40%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
6.93B
6 days until earnings call
Ad is loading...

AUPH vs RHP

Header iconAUPH vs RHP Comparison
Open Charts AUPH vs RHPBanner chart's image
Aurinia Pharmaceuticals
Price$8.19
Change+$0.09 (+1.11%)
Volume$5.73K
Capitalization1.11B
Ryman Hospitality Properties
Price$86.32
Change-$0.35 (-0.40%)
Volume$4.88K
Capitalization6.93B
AUPH vs RHP Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. RHP commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongBuy and RHP is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AUPH: $8.10 vs. RHP: $86.67)
Brand notoriety: AUPH and RHP are both not notable
AUPH represents the Biotechnology, while RHP is part of the Real Estate Investment Trusts industry
Current volume relative to the 65-day Moving Average: AUPH: 67% vs. RHP: 44%
Market capitalization -- AUPH: $1.11B vs. RHP: $6.93B
AUPH [@Biotechnology] is valued at $1.11B. RHP’s [@Real Estate Investment Trusts] market capitalization is $6.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The market cap for tickers in the [@Real Estate Investment Trusts] industry ranges from $243.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B. The average market capitalization across the [@Real Estate Investment Trusts] industry is $5.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileRHP’s FA Score has 2 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • RHP’s FA Score: 2 green, 3 red.
According to our system of comparison, RHP is a better buy in the long-term than AUPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 6 TA indicator(s) are bullish while RHP’s TA Score has 4 bullish TA indicator(s).

  • AUPH’s TA Score: 6 bullish, 4 bearish.
  • RHP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than RHP.

Price Growth

AUPH (@Biotechnology) experienced а +4.52% price change this week, while RHP (@Real Estate Investment Trusts) price change was +1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.20%. For the same industry, the average monthly price growth was -4.19%, and the average quarterly price growth was -12.04%.

The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +0.90%. For the same industry, the average monthly price growth was -3.64%, and the average quarterly price growth was -8.67%.

Reported Earning Dates

AUPH is expected to report earnings on Jul 31, 2025.

RHP is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Real Estate Investment Trusts (+0.90% weekly)

A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHP($6.93B) has a higher market cap than AUPH($1.11B). AUPH has higher P/E ratio than RHP: AUPH (202.50) vs RHP (21.64). AUPH YTD gains are higher at: -9.800 vs. RHP (-15.881). RHP has higher annual earnings (EBITDA): 671M vs. AUPH (31.7M). RHP has more cash in the bank: 592M vs. AUPH (358M). AUPH has less debt than RHP: AUPH (79.4M) vs RHP (3.51B). RHP has higher revenues than AUPH: RHP (2.16B) vs AUPH (235M).
AUPHRHPAUPH / RHP
Capitalization1.11B6.93B16%
EBITDA31.7M671M5%
Gain YTD-9.800-15.88162%
P/E Ratio202.5021.64936%
Revenue235M2.16B11%
Total Cash358M592M60%
Total Debt79.4M3.51B2%
FUNDAMENTALS RATINGS
AUPH vs RHP: Fundamental Ratings
AUPH
RHP
OUTLOOK RATING
1..100
1853
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
10025
SMR RATING
1..100
8921
PRICE GROWTH RATING
1..100
4478
P/E GROWTH RATING
1..100
3847
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHP's Valuation (36) in the Real Estate Investment Trusts industry is somewhat better than the same rating for AUPH (88) in the Biotechnology industry. This means that RHP’s stock grew somewhat faster than AUPH’s over the last 12 months.

RHP's Profit vs Risk Rating (25) in the Real Estate Investment Trusts industry is significantly better than the same rating for AUPH (100) in the Biotechnology industry. This means that RHP’s stock grew significantly faster than AUPH’s over the last 12 months.

RHP's SMR Rating (21) in the Real Estate Investment Trusts industry is significantly better than the same rating for AUPH (89) in the Biotechnology industry. This means that RHP’s stock grew significantly faster than AUPH’s over the last 12 months.

AUPH's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for RHP (78) in the Real Estate Investment Trusts industry. This means that AUPH’s stock grew somewhat faster than RHP’s over the last 12 months.

AUPH's P/E Growth Rating (38) in the Biotechnology industry is in the same range as RHP (47) in the Real Estate Investment Trusts industry. This means that AUPH’s stock grew similarly to RHP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUPHRHP
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 24 days ago
74%
Declines
ODDS (%)
Bearish Trend 18 days ago
83%
Bearish Trend 10 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BLOK39.650.91
+2.35%
Amplify Transformational Data Shrg ETF
XBI80.891.79
+2.26%
SPDR® S&P Biotech ETF
EET52.301.12
+2.20%
ProShares Ultra MSCI Emerging Markets
SDSI51.100.15
+0.29%
American Century® Short Dur Str Inc ETF
PUTW30.15N/A
N/A
WisdomTree PutWrite Strategy Fund

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
+0.12%
JSPR - AUPH
44%
Loosely correlated
+7.24%
VCYT - AUPH
39%
Loosely correlated
+2.15%
CGON - AUPH
38%
Loosely correlated
+3.81%
SCPH - AUPH
37%
Loosely correlated
-3.85%
CMRX - AUPH
37%
Loosely correlated
N/A
More

RHP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHP has been closely correlated with APLE. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if RHP jumps, then APLE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHP
1D Price
Change %
RHP100%
+0.99%
APLE - RHP
85%
Closely correlated
+1.19%
DRH - RHP
84%
Closely correlated
+1.14%
PK - RHP
84%
Closely correlated
+1.01%
HST - RHP
82%
Closely correlated
+1.16%
XHR - RHP
82%
Closely correlated
+2.56%
More